Ignite Creation Date:
2024-05-06 @ 3:09 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04531046
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-09-26
First Post:
2020-08-25
Brief Title:
Axi-Cel as a 2nd Line Therapy in Patients With RelapsedRefractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell Transplantation
Sponsor:
The Lymphoma Academic Research Organisation
Organization:
The Lymphoma Academic Research Organisation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-10
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06
Completion Date Type:
ESTIMATED
First Submit Date:
2020-08-25
First Submit QC Date:
August 25 2020
Study First Post Date:
2020-08-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-08
Last Update Post Date:
2023-09-26
Last Update Post Date Type:
ACTUAL